Resmed launches AirTouch F40 fabric CPAP mask in the U.S. for improved comfort in sleep apnea therapy

Resmed has introduced the AirTouch F40, a new full-face fabric CPAP mask designed to enhance comfort and fit for people with obstructive sleep apnea (OSA) in the U.S. The mask features a soft, breathable ComfiSoft fabric cushion and a minimalist design that adapts to facial movements, aiming to improve long-term therapy adherence. With OSA affecting millions and CPAP therapy as the standard treatment, this launch offers patients more personalized mask options. The AirTouch F40 will be available starting October 28, 2026, and integrates with Resmed’s digital tools to support ongoing patient engagement and compliance.

ResMed Inc. (RMD) shares are trading at USD 238.97 on Pluang as of Oct 19, 2026 19:12 WIB, holding steady with a 0.00% change for the day. This price sits comfortably between its 52-week low of USD 182.82 and high of USD 275.96, reflecting a mid-range valuation. The stock’s typical hold time on Pluang is 51 days, and it offers a dividend yield of 1.1%, providing some income alongside potential growth.